Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion.
about
Insulin-like growth factor-1 deficiency and metabolic syndromeA low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans.Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humansInsulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humansGrowth hormone, IGF-I and insulin and their abuse in sport.The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes.Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.Insulin-like growth factor-1 stimulates regulatory T cells and suppresses autoimmune disease.Pharmacodynamic considerations with recombinant human insulin-like growth factor-I in children.Amino acid infusion during anesthesia attenuates the surgery induced decline in IGF-1 and diminishes the "diabetes of injury".Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus.Insulin-like growth factor-1 and delirium in critically ill mechanically ventilated patients: a preliminary investigation.Insulin-like growth factor-I in Helicobacter pylori gastritis and response to eradication using bismuth based triple therapy.Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection.Insulin and GH-IGF-I axis: endocrine pacer or endocrine disruptor?Mechanisms of Melatonin in Alleviating Alzheimer's Disease.Prolonged sleep restriction affects glucose metabolism in healthy young men.The insulin-like growth factor-I/binding protein axis: physiology, pathophysiology and therapeutic manipulation.Insulin-like growth factor-1 is a negative modulator of glucagon secretion.Stimulation of glucose uptake by insulin-like growth factor II in human muscle is not mediated by the insulin-like growth factor II/mannose 6-phosphate receptor.Effects of insulin and insulin-like growth factors on protein and energy metabolism in tumour-bearing rats.IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes.Differential in vitro effects of insulin on Taenia crassiceps and Taenia solium cysticerci.Normalisation of insulin-like growth factor-I does not improve insulin action in cirrhosis.Effect of IGF-I therapy on VLDL apolipoprotein B100 metabolism in type 1 diabetes mellitus.Low serum insulin-like growth factor-binding protein-1 is associated with an unfavourable cardiovascular risk profile in elderly men.Insulin-like growth factor-I lowers fasting and postprandial triglyceride levels without affecting chylomicron clearance in healthy men.Free insulin-like growth factors (IGF-I and IGF-II) in human serum.Altered mental function during intravenous infusion of recombinant human insulin-like growth factor 1.
P2860
Q28072410-4627F2A8-E7F0-434C-92FD-F2F1C96E2BCAQ30449290-7F25D659-83D7-4BBC-A092-8E95AA69833FQ33905407-5E45DE56-7905-4259-A4F9-71BD8DC2338AQ33907536-A8324C3A-6615-4AA0-87DF-FB782EC290D3Q34010760-68C16899-A3C0-4480-A1B3-80BEDE29856EQ34127704-7FD98847-91AE-41E8-AA25-E6DD4D1D350CQ34184378-29D4911F-70C4-479F-A2A1-39BCFEE54ACBQ34542675-F14FCF4E-C15F-453C-B024-7C5F8C18ECA5Q35008035-545BAB3D-CA9A-4EBD-BC64-3EC2EC71BD28Q35606430-FBEA14DC-1D26-4924-B6B7-2094A38894BBQ35612844-630A7059-D397-4BA1-AF02-73BE131C52E4Q36845604-13C9B912-382F-4823-AF7C-192F23A92BADQ37220332-8A1291D3-CCBA-46E3-AC02-3C85860119C9Q38128225-2CC7D130-1EEF-4741-96F0-4DC43465BC89Q38239532-1F85E52D-64B1-4B56-9244-6A72995546F1Q39178920-FD32C4F9-CAC0-4A86-90A1-CF2EA337547DQ40122883-2524E55C-2E22-4261-8422-FB875946A42AQ40492402-B45A69D6-E5BA-4B0F-B6B1-32BB0548C92BQ41612986-34849973-1634-4924-A803-F15F28426582Q42160959-789D54DF-DFAF-4A16-9780-199E012CF60BQ42827768-98DAADE2-3FCC-41D9-8EFE-45D6AE320F42Q44129300-590E6F8F-EBCE-496E-8D46-4724EDFF8E51Q45956689-6E4AB1C2-A7B4-4727-A815-9F5904A8DB54Q51367271-70FAAF4E-37BF-49BE-BCD8-1F87210D4EDBQ51543747-2A3D79D1-D0D1-4583-B2DF-1925B78FC613Q51553189-F3F79451-C780-44CF-B78D-E602606E11C9Q51562983-A8AFF519-493E-46EA-851C-66514A69074CQ51594543-458E0C6B-E38B-4212-81F2-B52E81A5F4E0Q52016371-E36E3B4C-2246-4F88-B532-7B564719E7BE
P2860
Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Effects of insulin-like growth ...... levels, and insulin secretion.
@ast
Effects of insulin-like growth ...... levels, and insulin secretion.
@en
Effects of insulin-like growth ...... levels, and insulin secretion.
@nl
type
label
Effects of insulin-like growth ...... levels, and insulin secretion.
@ast
Effects of insulin-like growth ...... levels, and insulin secretion.
@en
Effects of insulin-like growth ...... levels, and insulin secretion.
@nl
prefLabel
Effects of insulin-like growth ...... levels, and insulin secretion.
@ast
Effects of insulin-like growth ...... levels, and insulin secretion.
@en
Effects of insulin-like growth ...... levels, and insulin secretion.
@nl
P2093
P2860
P356
P1476
Effects of insulin-like growth ...... levels, and insulin secretion.
@en
P2093
P2860
P304
P356
10.1172/JCI115796
P407
P577
1992-06-01T00:00:00Z